September 15, 2020 Acad, Gov/Utilities Environ, Ag./Food & Bev

GE Healthcare’s Clariscan™ (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle

US FDA approves +PLUSPAK™ (polymer bottle) Pharmacy Bulk Package for the gadolinium-based contrast agent, Clariscan™ (gadoterate meglumine) As the only polymer bottle for an MRI contrast agent, Clariscan in +PLUSPAK offers the potential for increased workplace safety, efficiency, convenience and environmental advantages Clariscan has been approved in more than 65 countries globally, with more than... Read more

September 1, 2020 Uncategorized

Health Canada Licenses First Artificial Intelligence Algorithms Embedded On-Device to Prioritize Critical Chest X-ray Review

Critical Care Suite helps radiologists prioritize critical cases with a suspected pneumothorax – a type of collapsed lung – by immediately flagging critical cases to radiologists for triage, which could drastically cut the average review time from up to eight hours[1] Offers first-of-its-kind automated AI quality check features that detect acquisition errors, flagging images for... Read more

July 30, 2020 PAI Top-10

GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)

Amersham, UK, Minnesota, USA, and Melbourne, Australia— 30 July 2020 — GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey.  Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare’s range of... Read more

June 18, 2020 Product Launch

GE Healthcare Launches New AI Suite to Detect Chest X-ray Abnormalities, Including Pneumonia Caused by COVID-19 & Tuberculosis

Chalfont St Giles, UK, June 18, 2020 – GE Healthcare today introduced its Thoracic Care Suite, a collection of eight artificial intelligence (AI) algorithms from Lunit Insight CXR to help alleviate clinical strain due to COVID-19. The AI suite quickly analyzes chest x-ray findings and flags abnormalities to radiologists for review, including pneumonia, which may... Read more

June 15, 2020 Acad, Gov/Utilities

GE Healthcare to collaborate with University of Oxford, NCIMI on AI algorithms to help predict COVID-19 severity, complications and long-term impact

Chalfont St Giles, UK – June 15 2020 GE Healthcare is working with the University of Oxford-led National Consortium of Intelligent Medical Imaging (NCIMI) in the UK to develop and test algorithms to aid in the diagnosis and management of COVID-19 pneumonia. The program will focus on developing, enhancing and testing potential algorithms to help... Read more

June 15, 2020 Product Launch

GE Healthcare, Orange Healthcare and TheraPanacea collaborate with Assistance Publique-Hôpitaux de Paris and Société d'Imagerie Thoracique to create COVID-19 database and develop new AI-based tools

Paris, France –15 June 2020: GE Healthcare, Orange Healthcare and TheraPanacea plan a collaboration with Assistance Publique-Hôpitaux de Paris to create a database around chest imaging in patients suspected of being infected with SARS-Cov-2, the virus responsible for Covid-19. This collaboration supports the STOIC project (ThOracian Scanner for the dIagnosis of Coronavirus19 pneumonia – COVID-19)... Read more

June 15, 2020 Product Launch

GE Healthcare, Orange Healthcare and TheraPanacea collaborate with Assistance Publique-Hôpitaux de Paris and Société d'Imagerie Thoracique to create COVID-19 database and develop new AI-based tools

Paris, France –15 June 2020: GE Healthcare, Orange Healthcare and TheraPanacea plan a collaboration with Assistance Publique-Hôpitaux de Paris to create a database around chest imaging in patients suspected of being infected with SARS-Cov-2, the virus responsible for Covid-19. This collaboration supports the STOIC project (ThOracian Scanner for the dIagnosis of Coronavirus19 pneumonia – COVID-19)... Read more

June 9, 2020 Acad, Gov/Utilities PR/Corporate

GE Healthcare Receives FDA Clearance of the Industry’s First Contrast-Enhanced Mammography Solution for Biopsy

Chicago, Illinois – June 9, 2020 – To help empower clinicians and patients in their fight against breast cancer, GE Healthcare today announced the Food and Drug Administration’s 510(k) clearance of Pristina Serena Bright™*, the healthcare industry’s first contrast-enhanced mammography solution for https://www.genewsroom.com/press-releases/ge-healthcare-receives-fda-clearance-industry%E2%80%99s-first-contrast-enhanced-mammography Read more

May 27, 2020 Acad, Gov/Utilities

Shorter Scans and Better Image Quality: Deep Learning-Based MR Image Reconstruction Tech from GE Healthcare now FDA Cleared

Waukesha, WI – May 27, 2020 – GE Healthcare today announced U.S. FDA 510(k) clearance of AIR Recon DL. This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image quality across all anatomies. AIR Recon DL, developed on GE Healthcare’s... Read more

April 15, 2020 Microscopy

GE Healthcare Deploys Remote Patient Data Monitoring Technology to Help Clinicians Support Most Critical COVID-19 Patients across the Health System

Scaled using Microsoft Azure, GE Healthcare’s Mural Virtual Care Solution allows clinicians to view numerous ventilated patients simultaneously and remotely; enables early identification of patients at risk of deterioration CHICAGO – April 15, 2020 – GE Healthcare today introduced a new software solution to support clinicians and health systems in the treatment of COVID-19 patients.... Read more